CDLX
Cardlytics Inc
2.50$
-4.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 32.4% | 39.0% | 38.4% | 34.7% | 45.9% | 45.3% | 42.5% | 41.6% | 48.1% | 48.1% | 48.7% | 43.0% | |
| 14.2% | 16.0% | 17.2% | 13.3% | 16.8% | 16.7% | 14.1% | 12.9% | 15.0% | 17.1% | 13.5% | 11.9% | |
| 14.2% | 16.0% | 17.2% | 13.3% | 16.8% | 16.7% | 14.1% | 12.9% | 15.0% | 17.1% | 22.7% | 11.9% | |
| 17.0% | 21.9% | 19.5% | 20.1% | 27.4% | 27.3% | 26.9% | 26.8% | 31.2% | 29.8% | 24.9% | 30.0% | |
| 0.0% | – | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 55.6% | 48.3% | 48.7% | 51.9% | 39.9% | 40.6% | 43.2% | 44.1% | 37.7% | 38.6% | 41.8% | 47.0% | |
| 10.5% | 10.4% | 10.4% | 11.0% | 3.2% | 11.4% | 11.9% | 11.9% | 11.1% | 1.9% | 6.7% | 7.5% | |
| 64.5% | 76.5% | 65.0% | 60.7% | 82.5% | 82.2% | 82.6% | 83.7% | 101.6% | 102.3% | 101.5% | 106.8% | |
| 28.3% | 29.8% | 18.0% | 19.6% | 39.0% | 37.9% | 35.7% | 35.8% | 42.2% | 27.4% | 22.5% | 26.6% | |
| 5.1% | 0.4% | 0.4% | 0.4% | 12.1% | 12.2% | 12.9% | 13.1% | 16.3% | 0.6% | 0.6% | 7.0% | |
| 0.5% | 0.8% | 0.7% | 0.9% | 1.0% | 0.9% | 1.2% | 0.5% | 1.2% | 1.2% | 1.0% | 0.5% | |
| 35.8% | 44.9% | 45.3% | 39.8% | 41.9% | 42.7% | 45.5% | 46.6% | 57.6% | 73.1% | 77.4% | 78.5% | |
| 35.5% | 23.5% | 35.0% | 39.3% | 17.5% | 17.8% | 17.4% | 16.3% | -1.6% | -2.3% | -1.5% | -6.8% | |
| -159.1% | -193.6% | -199.6% | -213.3% | -321.7% | -331.2% | -356.0% | -366.4% | -476.7% | -491.5% | -533.7% | -606.3% | |
| 0.6% | 0.7% | 0.8% | 0.9% | 1.3% | 1.3% | 1.4% | 1.5% | 1.8% | 1.9% | 2.1% | 2.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.